No headlines found.
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
Globe Newswire (Wed, 27-Mar 8:00 AM ET)
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives
Globe Newswire (Mon, 11-Mar 8:00 AM ET)
Business Wire (Fri, 1-Mar 4:00 AM ET)
R1 RCM Reports Fourth Quarter and Full Year 2023 Results
Globe Newswire (Tue, 27-Feb 7:00 AM ET)
Business Wire (Mon, 26-Feb 3:54 PM ET)
R1 RCM to Present at Upcoming Investor Conferences
Globe Newswire (Fri, 16-Feb 5:00 PM ET)
R1 Wins Multiple Best in KLAS Awards for Third Straight Year
Globe Newswire (Wed, 7-Feb 8:00 AM ET)
R1 RCM Completes Acquisition of Acclara, Providence's Modular Services Business
Globe Newswire (Wed, 17-Jan 4:05 PM ET)
R1 RCM Announces Preliminary Fourth Quarter Results
Globe Newswire (Mon, 8-Jan 7:00 AM ET)
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
R1 Rcm trades on the NASDAQ stock market under the symbol RCM.
As of March 28, 2024, RCM stock price declined to $12.88 with 3,600,761 million shares trading.
RCM has a beta of 1.23, meaning it tends to be more sensitive to market movements. RCM has a correlation of 0.12 to the broad based SPY ETF.
RCM has a market cap of $5.41 billion. This is considered a Mid Cap stock.
Last quarter R1 Rcm reported $575 million in Revenue and $.00 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.02.
In the last 3 years, RCM stock traded as high as $27.95 and as low as $6.71.
The top ETF exchange traded funds that RCM belongs to (by Net Assets): IJH, VTI, VB, VXF, VBK.
RCM has underperformed the market in the last year with a price return of -11.5% while the SPY ETF gained +33.6%. However, in the short term, RCM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +20.4% vs +10.1% return in SPY. But in the last 2 weeks, RCM shares have been beat by the market, returning -7.7% compared to an SPY return of +1.7%.
RCM support price is $12.75 and resistance is $13.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RCM stock will trade within this expected range on the day.